https://scholars.lib.ntu.edu.tw/handle/123456789/630918
標題: | Cancer-Associated Thrombosis: A Taiwanese Perspective on Therapeutic Options with Focus on Non-Vitamin K Antagonist Oral Anticoagulants | 作者: | YU-YUN SHAO Ho, Ching-Liang Chang, Cheng-Shyong Chang, Chia-Lun JEN-KUANG LEE HUNG-JU LIN Hsiao, Hui-Hua Chao, Ta-Chung Lin, Ching-Yeh Liaw, Chuang-Chi |
關鍵字: | Cancer-associated thrombosis; Deep venous thromboembolism; Evidence-based guidelines; Non-vitamin K antagonist oral anticoagulants; Pulmonary embolism | 公開日期: | 三月-2023 | 出版社: | TAIWAN SOC CARDIOLOGY | 卷: | 39 | 期: | 2 | 起(迄)頁: | 242 | 來源出版物: | Acta Cardiologica Sinica | 摘要: | Cancer-associated thrombosis (CAT) is a common complication of malignancies. Patients with CAT are at risk of venous thromboembolism recurrence, but also at risk of bleeding while anticoagulated. Taiwanese patients are perceived to have a lower incidence of CAT, likely leading to false reassurance for Taiwanese patients with cancer. Because of this, oncologists and cardiologists from multiple medical institutions in Taiwan have set forth to provide clinical consensus guidelines on the management of CAT, based on local clinical practices and guided by predominant international clinical practice guidelines. This paper aims to describe the current disease burden of cancer-associated venous thromboembolism in Taiwanese cancer patients, and discusses the unmet needs and gaps in the management of this medical complication. It also outlines diagnostic and management strategies relevant to the different treatment options available, such as non-vitamin K antagonist oral anticoagulants. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/630918 | ISSN: | 1011-6842 | DOI: | 10.6515/ACS.202303_39(2).20220719A |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。